XML 20 R6.htm IDEA: XBRL DOCUMENT v3.22.1
UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-In Capitol
Comprehensive Income
Retained Earnings
Total
Equity Balance, value at Dec. 31, 2018 $ 37 $ 122 $ (11,290) $ 100,123 $ 88,992
Equity Balance, shares at Dec. 31, 2018 3,720        
Common stock issued upon exercise of employee stock options $ 0 290 0 0 290
Common stock issued upon exercise of employee stock options, shares 7        
Common stock received and retired upon exercise of stock options $ 0 (7) 0 0 (7)
Common stock received and retired upon exercise of stock options, shares 0        
Stock option compensation expense $ 0 113 0 0 113
Common stock purchased and retired $ 0 (499) 0 101 (398)
Common stock purchased and retired, shares (5)        
Foreign currency translation adjustment $ 0 0 1,507 0 1,507
Common stock dividends 0 0 0 (4,132) (4,132)
Net income 0 0 0 14,727 14,727
Equity Balance, value at Dec. 31, 2019 $ 37 18 (9,782) 110,820 101,093
Equity Balance, shares at Dec. 31, 2019 3,722        
Common stock issued upon exercise of employee stock options $ 0 358 0 0 358
Common stock issued upon exercise of employee stock options, shares 8        
Stock option compensation expense $ 0 160 0 0 160
Common stock purchased and retired $ (1) (421) 0 (6,555) (6,976)
Common stock purchased and retired, shares (87)        
Foreign currency translation adjustment $ 0 0 1,502 0 1,502
Common stock dividends 0 0 0 (4,112) (4,112)
Net income 0 0 0 10,798 10,798
Equity Balance, value at Dec. 31, 2020 $ 36 115 (8,280) 110,951 102,822
Equity Balance, shares at Dec. 31, 2020 3,643        
Common stock issued upon exercise of employee stock options $ 0 787 0 0 787
Common stock issued upon exercise of employee stock options, shares 14        
Common stock received and retired upon exercise of stock options $ 0 (227) 0 0 (227)
Common stock received and retired upon exercise of stock options, shares (2)        
Stock option compensation expense $ 0 166 0 0 166
Foreign currency translation adjustment 0 0 (773) 0 (773)
Common stock dividends 0 0 0 (10,425) (10,425)
Net income 0 0 0 14,788 14,788
Equity Balance, value at Dec. 31, 2021 $ 36 $ 842 $ (9,053) $ 115,314 $ 107,138
Equity Balance, shares at Dec. 31, 2021 3,655